Moderna says new Covid vaccine was effective against Eris variant in early trial

[ad_1] Nikos Pekiaridis | Lightrocket | Getty Images Moderna’s new Covid vaccine generated a robust immune…

Appeals court imposes restrictions on abortion pill, but drug will stay on the market for now

[ad_1] A container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared…

SEC investigating Illumina over acquisition of cancer test developer Grail

[ad_1] A building on the campus at the world headquarters of Illumina is shown in San…

These 10 medications are likely targets for Medicare price negotiations this fall

[ad_1] Merck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker…

Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion

[ad_1] Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire…

Novavax shares jump after Covid vaccine maker posts surprise quarterly profit

[ad_1] Medical syringes and Novavax logo displayed in the background are seen in this illustration photo…

Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug

[ad_1] In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a…

Pfizer limits distribution of some drugs from North Carolina plant damaged by tornado

[ad_1] The roof of a Pfizer facility shows heavy damage after a tornado passed the area…

Infant RSV shot wins CDC backing, paving way for fall availability

[ad_1] A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic…

Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales

[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech…

CVS beats on earnings and revenue as the company slashes costs

[ad_1] A customer exits a CVS Health Corp. store in Oakland, California, U.S., on Friday, Aug.…

Pfizer misses revenue estimates, says it may cut costs if Covid product sales continue to disappoint

[ad_1] Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Tuesday reported second-quarter adjusted earnings that…

NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies

[ad_1] Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture…

New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why

[ad_1] A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez |…

Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time

[ad_1] In this photo illustration, a container of Johnson and Johnson baby powder is displayed on…

Newseum Global